Pasar al contenido principal

ESTUDIO DE PROTEINAS MODIFICADAS LIPIDICAMENTE: SONIC HEDGEHOG, LC3 Y HETEROGENEIDAD LIPIDICA.

RTI2018-096323-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dinuclear silver and gold bisNHC complexes as drug candidates for cancer therapy

  • Quintana, Mireia
  • Rodriguez-Rius, Alba
  • Vellé, Alba
  • Vives, Sonia
  • Sanz Miguel, Pablo J.
  • Triola Guillem, Gemma
We report four dinuclear silver(I) and gold(I) complexes containing two different bidentate N-heterocyclic carbene ligands (bisNHC). One of these complexes 4, shows strong and selective anticancer activity against the human ovarian cancer cell line A2780. Mechanistically, 4 enhances the oxidative stress by stimulating reactive oxygen species production and inhibiting the scavenging activity of thioredoxin reductase. Our findings provide evidence that tuning ligand and electronic properties of metal-NHC complexes can modulate their reactivity and selectivity and it may result in potential novel anticancer drugs., We acknowledge financial support from Ministerio de Ciencia e Innovación, Spain (RTI2018-096323-B-I00), the Marie Curie Career Integration Grants (PCIG12-GA-2012-33835), the Max Planck Society (MPG Partner Group), the Aragon Government (E42_20R) and the University of Zaragoza., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Dinuclear silver and gold bisNHC complexes as drug candidates for cancer therapy

  • Quintana, M.
  • Rodriguez-Rius, A.
  • Vellé, A.
  • Vives, S.
  • Sanz Miguel, P.J.
  • Triola, G.
We report four dinuclear silver(I) and gold(I) complexes containing two different bidentate N-heterocyclic carbene ligands (bisNHC). One of these complexes 4, shows strong and selective anticancer activity against the human ovarian cancer cell line A2780. Mechanistically, 4 enhances the oxidative stress by stimulating reactive oxygen species production and inhibiting the scavenging activity of thioredoxin reductase. Our findings provide evidence that tuning ligand and electronic properties of metal-NHC complexes can modulate their reactivity and selectivity and it may result in potential novel anticancer drugs.